All posts tagged
German Biotech Unveils Positive Phase II Results for Alzheimer’s
Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic
Swiss Biotech Upgrades its Cancer Vaccine with Checkpoint Inhibitors
Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?
Merck Outsources the Development of its Nanobody for Psoriasis
You Can Now Search Worldwide Genomic Data in a Single Platform
Make your Biotech Career blossom with this Week’s best Job Offers!
More News! Merck KGaA to drop Biosimilars? Sanofi buys into RSV
The Best Jobs in the Biotech Universe: Join Biogen or Pfizer
A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa
Make your Biotech Career skyrocket! The Best Jobs of the Week await you!
World Cancer Day is Saturday! Europe’s Oncology in Numbers
Labiotech UG, All Rights Reserved -
Send this to friend